comparemela.com

Latest Breaking News On - Biotest aktiengesellschaft - Page 4 : comparemela.com

Biotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significan

Biotest AG / Key word(s): AllianceBiotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significantly raised28-Apr-2023 / 10:04 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group A.

Comunidad autonoma de catalunaDirk neumMonika buttkereitBiotest aktiengesellschaftMichael ramrothGrifols groupA technology transfer agreementDistribution servicesAbuse regulationSupervisory boardTechnology transfer agreementLicense agreementPrime standardRegulatory announcementsCorporate news

Biotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significantly raised

EQS-Ad-hoc: Biotest AG / Key word: Alliance Biotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significantly raised 28-Apr-2023 / 10:04 CET/CEST Disclosure. | April 28, 2023

Comunidad autonoma de catalunaBiotest aktiengesellschaftMonika buttkereitDirk neumMichael ramrothA technology transfer agreementGrifols groupAbuse regulationSupervisory boardTechnology transfer agreementLicense agreementPrime standardBiotest ag stock exchangePress releaseAised bio3 de0005227235

EQS-Adhoc: Biotest AG: Biotest significantly exceeds EBIT guidance 2022

EQS-Ad-hoc: Biotest AG / Key word(s): Preliminary Results Biotest AG: Biotest significantly exceeds EBIT guidance 2022 09-Feb-2023 / 14:19 CE.

Dirk neumMonika buttkereitBiotest aktiengesellschaftMichael ramrothBiotest groupAbuse regulationGerman commercial codeManagement boardSupervisory boardAnnual generalPrime standard

Investegate |Biotest AG Announcements | Biotest AG: Biotest significantly exceeds EBIT guidance 2022

Investegate announcements from Biotest AG, Biotest significantly exceeds EBIT guidance 2022

Dirk neumMonika buttkereitBiotest aktiengesellschaftMichael ramrothBiotest groupAbuse regulationGerman commercial codeManagement boardSupervisory boardAnnual generalPrime standardInvestegate announcementsInvestegate company announcementsIotest agQs and eqs

Biotest AG: Biotest exceeds Revenue guidance 2021

16.02.2022 Biotest AG: Biotest exceeds Revenue guidance 2021 | Biotest AG | News | Nachricht | Mitteilung

Dirk neumMonika buttkereitBiotest aktiengesellschaftMichael ramrothMarket abuse regulationFinancial yearPrime standardD hoc

vimarsana © 2020. All Rights Reserved.